Copyright
©The Author(s) 2022.
World J Gastroenterol. Jun 21, 2022; 28(23): 2597-2608
Published online Jun 21, 2022. doi: 10.3748/wjg.v28.i23.2597
Published online Jun 21, 2022. doi: 10.3748/wjg.v28.i23.2597
Figure 2 Tertile analysis of infliximab and adalimumab trough levels for patients with fistula healing and fistula closure.
A: Infliximab; B: Adalimumab.
- Citation: Gu B, Venkatesh K, Williams AJ, Ng W, Corte C, Gholamrezaei A, Ghaly S, Xuan W, Paramsothy S, Connor S. Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn’s disease. World J Gastroenterol 2022; 28(23): 2597-2608
- URL: https://www.wjgnet.com/1007-9327/full/v28/i23/2597.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i23.2597